GlassScriptPhysician profile
Connor Gill
NPI 1699026310
$1,401.23
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $180 · 2022: $375 · 2023: $670 · 2024: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $297.82 | 2023-2024 | Impella |
| Zimmer Biomet Holdings, INC. | $219.68 | 2023-2024 | |
| Edwards Lifesciences Corporation | $140.09 | 2021-2024 | Mitris Resilia Mitral Valve, Konect Resilia |
| Genentech USA, INC. | $125.00 | 2022 | |
| Baxter Healthcare | $99.63 | 2021-2023 | Tisseel |
| Csl Behring | $97.09 | 2021-2023 | Kcentra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.22 | 2021-2023 | Lifevest |
| Ethicon US, LLC | $88.98 | 2021-2023 | Surgicel Nu-Knit, Prolene, Echelon Endopath |
| Haemonetics Corporation | $42.78 | 2022 | |
| Getinge USA Sales, LLC | $28.01 | 2021 | |
| Davol INC. | $26.20 | 2021 | |
| Ambu INC. | $23.75 | 2022 | |
| Smith+Nephew, INC. | $23.30 | 2022 | |
| Becton, Dickinson and Company | $23.11 | 2022 | |
| Lilly USA, LLC | $22.44 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $18.41 | 2022 | |
| Atricure, INC. | $16.12 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connor Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.